Xiaobo Mao

1.4k total citations
40 papers, 1.0k citations indexed

About

Xiaobo Mao is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Xiaobo Mao has authored 40 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Immunology and 6 papers in Cancer Research. Recurrent topics in Xiaobo Mao's work include Atherosclerosis and Cardiovascular Diseases (14 papers), T-cell and B-cell Immunology (8 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Xiaobo Mao is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (14 papers), T-cell and B-cell Immunology (8 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Xiaobo Mao collaborates with scholars based in China, United States and Poland. Xiaobo Mao's co-authors include Qiutang Zeng, Xiang Cheng, Yucheng Zhong, Xiaoqi Zhao, Guiwen Yi, Min Cheng, Kai Meng, Bangwei Wu, Qiutang Zeng and Ruirui Zhu and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Xiaobo Mao

37 papers receiving 1.0k citations

Peers

Countries citing papers authored by Xiaobo Mao

Since Specialization

Citations

This map shows the geographic impact of Xiaobo Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobo Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobo Mao more than expected).

Fields of papers citing papers by Xiaobo Mao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobo Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobo Mao. The network helps show where Xiaobo Mao may publish in the future.

Co-authorship network of co-authors of Xiaobo Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobo Mao. A scholar is included among the top collaborators of Xiaobo Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobo Mao. Xiaobo Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Engineering exosomes for targeted neurodegenerative therapy: innovations in biogenesis, drug loading, and clinical translation 2025 ·Theranostics ·Qinqin Huang, Shile Wang, Zeming Liu, Lang Rao, Ke Cheng, Xiaobo Mao	0
2	A Prediction Model for Postoperative Pulmonary Complication in Pulmonary Function-Impaired Patients Following Lung Resection 2021 ·SHILAP Revista de lepidopterología ·Xiaobo Mao, (unknown), (unknown), Yilong Niu, (unknown)	0
3	Peripheral Blood Inflammatory-Immune Cells as a Predictor of Infertility in Women with Polycystic Ovary Syndrome 2020 ·SHILAP Revista de lepidopterología ·(unknown), Xiaobo Mao, Lei Huang, Binhua Dong, (unknown), Bo Zheng, (unknown)	2
4	IL-37 Plays a Beneficial Role in Patients with Acute Coronary Syndrome 2019 ·Mediators of Inflammation ·Xiaobo Mao, Ruirui Zhu, (unknown), (unknown), (unknown), Yuzhen Wei, (unknown), (unknown), (unknown), Yue Wang, Yan Ding, Qiutang Zeng	19
5	Circulating myocardial microRNAs from infarcted hearts are carried in exosomes and mobilise bone marrow progenitor cells 2019 ·Nature Communications ·Min Cheng, Junjie Yang, Xiaoqi Zhao, Eric Zhang, Qiutang Zeng, Yang Yu, Yang Liu, Bangwei Wu, Guiwen Yi, Xiaobo Mao, Kai Huang, Nianguo Dong, Min Xie, Nita A. Limdi, Sumanth D. Prabhu, Jianyi Zhang, Gangjian Qin	170
6	Digoxin reduces atherosclerosis in apolipoprotein E‐deficient mice 2016 ·British Journal of Pharmacology ·Huairui Shi, Xiaobo Mao, Yucheng Zhong, Yuzhou Liu, Xiaoqi Zhao, Kunwu Yu, Ruirui Zhu, Yuzhen Wei, (unknown), (unknown), Yi Mao, Qiutang Zeng	42
7	2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the preventionof sudden cardiac death 2015 ·Xiaobo Mao, (unknown)	1
8	Heme Oxygenase-1 Restores Impaired GARP+CD4+CD25+ Regulatory T Cells from Patients with Acute Coronary Syndrome by Upregulating LAP and GARP Expression on Activated T Lymphocytes 2015 ·Cellular Physiology and Biochemistry ·Yuzhou Liu, Xiaoqi Zhao, Yucheng Zhong, Kai Meng, Kunwu Yu, Huairui Shi, Bangwei Wu, (unknown), (unknown), Ruirui Zhu, Yudong Peng, Yi Mao, Cheng Peng, Xiaobo Mao, Qiutang Zeng	11
9	Serum Galectin‐9 Levels Are Associated with Coronary Artery Disease in Chinese Individuals 2015 ·Mediators of Inflammation ·Ruirui Zhu, (unknown), (unknown), Qiutang Zeng, Xiang Wang, Zhengfeng Zhu, Yuzhou Liu, Xiaobo Mao, Yucheng Zhong	26
10	Human umbilical vein endothelial cells promote the inhibitory activation of CD4+CD25+Foxp3+ regulatory T cells via PD-L1 2015 ·Atherosclerosis ·Weijun Chen, Xiao-Fan Hu, Min Yan, Wenyong Zhang, Xiaobo Mao, Yan‐Wen Shu	28
11	Impairment of Circulating CD4⁺CD25⁺GARP⁺Regulatory T Cells in Patients with Acute Coronary Syndrome 2014 ·Cellular Physiology and Biochemistry ·Kai Meng, (unknown), Yucheng Zhong, Xiaobo Mao, Yingzhong Lin, Ying Huang, Mingjian Lang, Yudong Peng, Zhengfeng Zhu, Yuzhou Liu, Xiaoqi Zhao, Kunwu Yu, Bangwei Wu, Qingwei Ji, Qiutang Zeng	18
12	Disruption of the TSLP-TSLPR-LAP signaling between epithelial and dendritic cells through hyperlipidemia contributes to regulatory T-Cell defects in atherosclerotic mice 2014 ·Atherosclerosis ·Kunwu Yu, Qian Dong, Xiaobo Mao, Kai Meng, Xiaoqi Zhao, Qingwei Ji, Bangwei Wu, Yucheng Zhong, Zhengfeng Zhu, Yuzhou Liu, (unknown), (unknown), Huairui Shi, Qiutang Zeng	17
13	IL-17A contributes to brain ischemia reperfusion injury through calpain-TRPC6 pathway in mice 2014 ·Neuroscience ·Jiancheng Zhang, Xiaobo Mao, Ting Zhou, Xiang Cheng, Yun Lin	73
14	Oxidized Low Density Lipoprotein Induced Caspase-1 Mediated Pyroptotic Cell Death in Macrophages: Implication in Lesion Instability? 2013 ·PLoS ONE ·Jing Lin, Xiling Shou, Xiaobo Mao, (unknown), (unknown), (unknown), Lei Wang, (unknown), Hongcheng Fang, Dazhu Li	72
15	Total cholesterol content of erythrocyte membranes is associated with the severity of coronary artery disease and the therapeutic effect of rosuvastatin 2012 ·Upsala Journal of Medical Sciences ·Yucheng Zhong, (unknown), Qiutang Zeng, Xiang Wang, Guiwen Yi, Kai Meng, Yi Mao, Xiaobo Mao	22
16	Overexpression of CXCL16 promotes a vulnerable plaque phenotype in Apolipoprotein E–Knockout Mice 2010 ·Cytokine ·Guiwen Yi, Qiutang Zeng, Xiaobo Mao, Min Cheng, Xiaofang Yang, Hongtao Liu, Yi Mao, Min Guo, (unknown), Yucheng Zhong	19
17	Relationships of adiponectin and matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio with coronary plaque morphology in patients with acute coronary syndrome 2008 ·Canadian Journal of Cardiology ·Min Cheng, Satwat Hashmi, Xiaobo Mao, (unknown)	36
18	Adipose tissue stromal cells transplantation in rats of acute myocardial infarction 2007 ·Coronary Artery Disease ·Bingong Li, Qiutang Zeng, Hongxiang Wang, Shiying Shao, Xiaobo Mao, Feng Zhang, Shuguo Li, (unknown)	39
19	Effect of cytokines secreted by human adipose stromal cells on endothelial cells 2006 ·Journal of Huazhong University of Science and Technology [Medical Sciences] ·Bingong Li, Qiutang Zeng, Hongxiang Wang, Xiaobo Mao	6
20	蛍光X線分析のための合金標準試料の調製及び応用 I 溶融亜鉛めっき合金の分析 1998 ·Fan Jia, Cheng Luo, (unknown), (unknown), (unknown), (unknown), Xiaobo Mao, Jin Wen	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact